In 2012, the Dukakis Center conducted an evaluation of the Massachusetts Life Sciences Initiative and the associated Massachusetts Life Sciences Center (MLSC). The analysis showed the policy has had a significant and positive economic impact on the state’s life sciences sector, and encourages lawmakers to continue to invest in and provide support to these industries.
This report provides an up-to-date, independent evaluation of the $1 billion, 10-year Massachusetts Life Sciences Initiative and the Massachusetts Life Sciences Center (MLSC) charged with the responsibility of carrying out its mission. The initiative was established in July 2008 by Governor Deval Patrick’s Administration and the Legislature to encourage the growth of discovery and production in the life sciences, including biotechnology, pharmaceuticals, medical diagnostics, medical devices and bioinformatics in the Commonwealth. Based on the region’s existing comparative advantage in life sciences research and development (R&D) emanating from the laboratories of its leading universities and medical institutions, this substantial infusion of public funds was undertaken with the ambitious goal of making this cluster of industry sectors the most successful in the world.